ESMO Launches New Peer-Reviewed Journal Focused on AI in Cancer Care

The European Society for Medical Oncology (ESMO) has launched a new peer-reviewed journal, ESMO Artificial Intelligence and Oncology, dedicated to artificial intelligence applications in cancer research and clinical oncology. The journal aims to promote rigorous validation and multidisciplinary collaboration to support safe integration of AI in oncology practice.

Cover image of the newly launched ESMO journal dedicated to artificial intelligence in oncology, showing digital cancer research concepts.

AI News and Advances in Oncology

Part 1 of 1

1
ESMO Launches New Peer-Reviewed Journal Focused on AI in Cancer Care

Table of Contents

    The European Society for Medical Oncology (ESMO) announced on November 16, 2026, the launch of ESMO Artificial Intelligence and Oncology, a new peer-reviewed journal focused on the application of artificial intelligence (AI) in cancer research and clinical care. The announcement coincided with the opening of the second ESMO AI and Digital Oncology Congress in Lugano, Switzerland.

    The journal provides a dedicated platform for publishing original research, reviews, editorials, and educational content related to AI’s role in pathology, molecular profiling, diagnostic imaging, clinical decision support, drug development, healthcare workflows, regulatory issues, medical education, and health economics within oncology.

    Under Editor-in-Chief Prof. Dr. med. Jakob Nikolas Kather, the journal emphasizes methodological rigor, transparency, and multidisciplinary collaboration among oncologists, data scientists, and computational researchers. It aims to support clinicians and researchers in evaluating and validating AI tools before clinical implementation.

    Operating with continuous online publication and a robust peer-review process, ESMO Artificial Intelligence and Oncology seeks to accelerate dissemination of scientific evidence and practical guidance for integrating AI into cancer care. This initiative complements ESMO’s ongoing activities in AI, including policy development, educational programs, and its annual AI and Digital Oncology Congress.

    Representing over 50,000 oncology professionals worldwide, ESMO reinforces its commitment to improving cancer patient outcomes through responsible AI innovation and application.

    ESMO Launches New Peer-Reviewed Journal Dedicated to Cancer Artificial Intelligence

    Share this article

    Related Posts